Group One Trading’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$453K Sell
28,500
-58,900
-67% -$1.28M ﹤0.01% 3434
2025
Q4
$2.3M Sell
87,400
-69,900
-44% -$1.81M ﹤0.01% 2168
2025
Q3
$3.55M Buy
157,300
+127,700
+431% +$2.63M 0.01% 1786
2025
Q2
$588K Buy
29,600
+13,100
+79% +$255K ﹤0.01% 3248
2025
Q1
$279K Buy
+16,500
New +$281K ﹤0.01% 3681
2024
Q3
Sell
-300
Closed -$5.89K 6841
2024
Q2
$5.89K Sell
300
-900
-75% -$18.8K ﹤0.01% 5881
2024
Q1
$26K Sell
1,200
-2,900
-71% -$72K ﹤0.01% 5234
2023
Q4
$119K Sell
4,100
-9,500
-70% -$254K ﹤0.01% 4313
2023
Q3
$364K Buy
13,600
+10,100
+289% +$345K ﹤0.01% 3243
2023
Q2
$130K Sell
3,500
-2,200
-39% -$76.7K ﹤0.01% 4361
2023
Q1
$178K Sell
5,700
-8,800
-61% -$283K ﹤0.01% 3780
2022
Q4
$432K Sell
14,500
-14,500
-50% -$519K ﹤0.01% 3181
2022
Q3
$1.1M Buy
29,000
+18,300
+171% +$917K ﹤0.01% 2477
2022
Q2
$583K Sell
10,700
-19,800
-65% -$1.09M ﹤0.01% 3277
2022
Q1
$1.9M Sell
30,500
-34,600
-53% -$2.28M ﹤0.01% 2438
2021
Q4
$6.55M Buy
65,100
+2,800
+4% +$246K 0.01% 1460
2021
Q3
$5.6M Buy
62,300
+20,700
+50% +$1.88M 0.01% 1574
2021
Q2
$3.84M Sell
41,600
-61,500
-60% -$4.91M ﹤0.01% 1953
2021
Q1
$9.96M Buy
103,100
+70,600
+217% +$7.29M 0.01% 949
2020
Q4
$1.69M Buy
32,500
+10,100
+45% +$422K ﹤0.01% 2188
2020
Q3
$897K Buy
+22,400
New +$701K ﹤0.01% 2300

Other funds holding FLGT

Group One Trading's FLGT Position: Q3 2025 in Review

Group One Trading sold out of Fulgent Genetics (FLGT) in Q3 2025, closing a stake of 7,347 shares — an estimated $151K sold.

Group One Trading first reported a position in FLGT in Q3 2020 and held it in 16 quarters. The position peaked at $1.27M in Q2 2021. 163 funds tracked by Wall St. Rank hold FLGT as of Q3 2025.

  • Group One Trading reported no remaining Fulgent Genetics position as of Q3 2025 after selling out during the quarter.
  • Group One Trading sold 7,347 Fulgent Genetics shares in Q3 2025, an estimated $151K.
  • Group One Trading first reported a position in Fulgent Genetics in Q3 2020 and held it in 16 quarters.
  • Group One Trading's Fulgent Genetics position peaked at $1.27M in Q2 2021.
  • 163 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2025.

Based on Group One Trading's 13F filing for Q3 2025, filed 12 Nov 2025.